United Kingdom — Barts Health NHS Trust
Tracked across 3 events · 33 articles · First seen Apr 21, 2026 · Last active Jun 07, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
Scientists have reported promising results from a groundbreaking gene-editing therapy, VERVE-102, developed by Verve PCSK9-inhibitor gene therapy>>>, a subsidiary of Eli Lilly and Company>>>. This therapy aims to permanently reduce 'bad' cholesterol (LDL cholesterol) after…
Impact: United Kingdom — Barts Health NHS Trust>>> contributed clinicians and scientists to the VERVE-102 research, aiding in the clinical trial and publication of findings.
May 26, 2026 · 12 articles
Domestic
An independent review led by Jonathan Mann, Baron Mann>>> has recommended that United Kingdom — National Health Service>>> staff in the United Kingdom>>> be prohibited from wearing political badges, including pro-Palestinian and pro-Israeli symbols, on…
Impact: United Kingdom — Barts Health NHS Trust>>> is facing legal action over its dress code policy, which is seen by some as discriminatory against pro-Palestinian beliefs, highlighting potential challenges in implementing the new recommendations.
Jun 03, 2026 · 14 articles
10
United Kingdom — Barts Health NHS Trust faces legal actionUK NHS bans political badges
NEWSDESK
Track United Kingdom — Barts Health NHS Trust live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard